Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

about

In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles

P2860

Q35585791-D683036F-019C-473B-84DA-F155CD1557F4

P2860

Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

Item

http://www.wikidata.org/entity/Q36941850

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

@en

type

Item

label

Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

@en

prefLabel

Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

@en

P1476

Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

@en

P2093

Gregory Ducrocq

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Tanguay

http://www.w3.org/2001/XMLSchema#string

Victor Serebruany

http://www.w3.org/2001/XMLSchema#string

P2860

Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity

Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Stent thrombosis is associated with an impaired response to antiplatelet therapy

Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study

Late angiographic stent thrombosis (LAST) events with drug-eluting stents

P304

939-953

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.5.5.939

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17867923

http://www.w3.org/2001/XMLSchema#string

Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

about

P2860

P2860

Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698